Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Endrit Shahini

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Nutrients|July 12, 2025
Association Between Follistatin and PAI-1 Levels in MASLD Subjects Undergoing a Plant-Based Dietary InterventionNicole Cerabino, Caterina Bonfiglio, Martina Di Chito, et al.
Nutrients|February 25, 2023
The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and ObesityRoberta Rinaldi, Sara De Nucci, Fabio Castellana, et al.
Hepatology Communications|September 14, 2023
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective studyErica Villa, Rossella Donghia, Valentina Baldaccini, et al.
Frontiers in Immunology|June 20, 2025
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrumEndrit Shahini, Donatello Marziliano, Francesco Losito, et al.
Inflammatory Bowel Diseases|April 25, 2018
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk FactorsMariabeatrice Principi, Andrea Iannone, Giuseppe Losurdo, et al.
Diabetes Research and Clinical Practice|November 9, 2024
Association between liver steatosis, fibrosis, and the onset of type 2 diabetes in overweight individuals: A fibroscan-based study in Southern ItalyDavide Guido, Nicole Cerabino, Martina Di Chito, et al.
World Journal of Gastroenterology|November 3, 2025
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinomaErica Villa, Rossella Donghia, Sergio Coletta, et al.
Journal of Translational Medicine|April 29, 2025
Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional studyGiuseppe Lisco, Davide Guido, Nicole Cerabino, et al.
Nutrients|October 28, 2023
Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and ObesitySara De Nucci, Caterina Bonfiglio, Rosanna Donvito, et al.
Nutrients|May 25, 2024
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic DietRoberta Rinaldi, Sara De Nucci, Rossella Donghia, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nutrients|July 12, 2025
Association Between Follistatin and PAI-1 Levels in MASLD Subjects Undergoing a Plant-Based Dietary InterventionNicole Cerabino, Caterina Bonfiglio, Martina Di Chito, et al.
Nutrients|February 25, 2023
The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and ObesityRoberta Rinaldi, Sara De Nucci, Fabio Castellana, et al.
Hepatology Communications|September 14, 2023
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective studyErica Villa, Rossella Donghia, Valentina Baldaccini, et al.
Frontiers in Immunology|June 20, 2025
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrumEndrit Shahini, Donatello Marziliano, Francesco Losito, et al.
Inflammatory Bowel Diseases|April 25, 2018
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk FactorsMariabeatrice Principi, Andrea Iannone, Giuseppe Losurdo, et al.
Diabetes Research and Clinical Practice|November 9, 2024
Association between liver steatosis, fibrosis, and the onset of type 2 diabetes in overweight individuals: A fibroscan-based study in Southern ItalyDavide Guido, Nicole Cerabino, Martina Di Chito, et al.
World Journal of Gastroenterology|November 3, 2025
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinomaErica Villa, Rossella Donghia, Sergio Coletta, et al.
Journal of Translational Medicine|April 29, 2025
Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional studyGiuseppe Lisco, Davide Guido, Nicole Cerabino, et al.
Nutrients|October 28, 2023
Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and ObesitySara De Nucci, Caterina Bonfiglio, Rosanna Donvito, et al.
Nutrients|May 25, 2024
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic DietRoberta Rinaldi, Sara De Nucci, Rossella Donghia, et al.
Pageof 6